Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms BES-4612 |
Target |
Mechanism MAPK13 inhibitors(mitogen-activated protein kinase 13 inhibitors), p38α inhibitors(P38 α mitogen-activated protein kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC64H67F2N7O12S |
InChIKeyRZMAGXNWPGZVNP-JCYIICMFSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | US | 10 Jan 2019 | |
Breast Cancer | Preclinical | US | 10 Jan 2019 |